PI
MRTX

Putnam Investments’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Putnam Investments’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-57,200
Closed -$9.24M – 837
2021
Q2 		$9.24M Buy
57,200
+23,344
+69% +$3.75M 0.01% 388
2021
Q1 		$5.8M Sell
33,856
-1,077
-3% -$213K 0.01% 470
2020
Q4 		$7.67M Sell
34,933
-1,258
-3% -$272K 0.01% 420
2020
Q3 		$6.01M Sell
36,191
-41
-0.1% -$5.61K 0.01% 443
2020
Q2 		$4.14M Sell
36,232
-149,054
-80% -$14.5M 0.01% 507
2020
Q1 		$14.2M Buy
185,286
+151,115
+442% +$13.6M 0.04% 263
2019
Q4 		$4.4M Sell
34,171
-43,386
-56% -$4.18M 0.01% 539
2019
Q3 		$6.04M Buy
77,557
+21,197
+38% +$1.99M 0.01% 470
2019
Q2 		$5.8M Sell
56,360
-95,451
-63% -$7.43M 0.01% 483
2019
Q1 		$11.1M Sell
151,811
-284,688
-65% -$19.4M 0.03% 334
2018
Q4 		$18.5M Buy
436,499
+382,051
+702% +$15.2M 0.05% 234
2018
Q3 		$2.56M Buy
54,448
+31,490
+137% +$1.75M 0.01% 718
2018
Q2 		$1.13M Sell
22,958
-670,609
-97% -$25.3M ﹤0.01% 831
2018
Q1 		$21.3M Sell
693,567
-246,041
-26% -$6.83M 0.05% 256
2017
Q4 		$17.1M Buy
+939,608
New +$14.6M 0.04% 297

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Putnam Investments's MRTX Position: Q3 2021 in Review

Putnam Investments sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q3 2021, closing a stake of 57,200 shares — an estimated $9.24M sold.

Putnam Investments first reported a position in MRTX in Q4 2017 and held it in 15 quarters. The position peaked at $21.3M in Q1 2018. 238 funds tracked by Wall St. Rank hold MRTX as of Q3 2021.

  • Putnam Investments reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Putnam Investments sold 57,200 Mirati Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $9.24M.
  • Putnam Investments first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2017 and held it in 15 quarters.
  • Putnam Investments's Mirati Therapeutics, Inc. Common Stock position peaked at $21.3M in Q1 2018.
  • 238 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Putnam Investments's 13F filing for Q3 2021, filed 15 Nov 2021.